An international multidisciplinary consensus on pediatric metabolic dysfunction-associated fatty liver disease

Area of Science:

• Hepatology
• Pediatric Endocrinology
• Metabolic Disorders

Background:

• Non-alcoholic fatty liver disease (NAFLD) is a common condition in obese children and adolescents.
• NAFLD is linked to metabolic syndrome components like insulin resistance and dyslipidemia.
• Metabolic dysfunction-associated fatty liver disease (MAFLD) is proposed to better describe the condition's pathophysiology.

Purpose of the Study:

• To develop consensus statements and recommendations for pediatric MAFLD.
• To establish standardized approaches for diagnosis and management.
• To improve clinical outcomes and quality of life for affected children.

Main Methods:

• A global consensus development process involving 65 experts from 35 countries.
• Surveys and iterative rounds to achieve expert agreement on draft statements.
• Inclusion of pediatricians, hepatologists, and endocrinologists.

Main Results:

• High levels of expert agreement were achieved on draft statements regarding pediatric MAFLD.
• Consensus was reached on epidemiology, pathophysiology, screening, and management strategies.
• Final statements provide a comprehensive framework for clinical practice.

Conclusions:

• Consensus statements offer optimized clinical outcomes for pediatric MAFLD.
• Recommendations aim to enhance the quality of life for children with MAFLD.
• Standardized diagnostic and treatment approaches are crucial for pediatric MAFLD.